Pharmaceutical Manufacturing Market by Drug Type, Dosage Form, Manufacturing Stage, Molecule Type, Manufacturing Technology, End-User, Therapeutic Area - Global Forecast 2025-2030- Product Image

Sale

Pharmaceutical Manufacturing Market by Drug Type, Dosage Form, Manufacturing Stage, Molecule Type, Manufacturing Technology, End-User, Therapeutic Area - Global Forecast 2025-2030

Report
187 Pages
August 2025
Region: Global
360iResearch™
ID: 5896347

UP TO €619EUR$697USD£537GBP OFF until Dec 31^st 2025

The pharmaceutical manufacturing market is entering a pivotal era of transformation, shaped by evolving regulations, technological innovations, and shifting global supply networks. Senior executives must recalibrate their strategies to capitalize on new production paradigms and ensure resilience as industry change accelerates.

Market Snapshot: Pharmaceutical Manufacturing Market Size & Growth

The pharmaceutical manufacturing market grew from USD 672.44 billion in 2024 to USD 731.63 billion in 2025 and is projected to reach USD 1.11 trillion by 2030, delivering a compound annual growth rate of 8.73%. Ongoing acceleration is driven by advancements in production technology, the increasing focus on biologics and personalized medicine, and changes in the regulatory environment. Manufacturers must adapt to rapid changes in quality expectations, digital integration, and sustainability imperatives to maintain competitive positioning.

Scope & Segmentation: Market Structure and Coverage

This report delivers comprehensive insights across multiple market dimensions and geographies, enabling executives to identify critical growth opportunities and operational risks. Segmentation includes:

Drug Type: Biosimilars, branded drugs, and generic drugs
Dosage Form: Liquids (emulsions, solutions, suspensions), parenteral (infusion, injectables—prefilled syringes, vials), solids (capsules, powders, tablets)
Manufacturing Stage: API manufacturing, formulation manufacturing, packaging and labelling
Molecule Type: Large molecule and small molecule drugs
Manufacturing Technology: Batch manufacturing, continuous manufacturing, single-use technology
End-User: Biotechnology companies, contract research organizations, government and public health bodies, pharmaceutical firms, research and academic institutes
Therapeutic Area: Cardiovascular, endocrinology (e.g., diabetes), gastroenterology, immunology, infectious diseases, neurology, oncology, rare diseases, respiratory
Geography: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe/Middle East/Africa (including major and emerging markets), Asia-Pacific (including China, India, Japan, Australia, Southeast Asia, and others)
Key Companies: Pfizer Inc., Roche Holding AG, Johnson & Johnson, Merck KGaA, Novartis AG, AbbVie Inc., Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, ACG Pvt. Ltd., Mankind Pharma Ltd.

Key Takeaways for Senior Decision-Makers

Technology adoption is reshaping production, with artificial intelligence, digital twins, and continuous manufacturing platforms optimizing process efficiency, yield, and supply chain agility.
The trend toward personalized medicine and biologics is driving the reevaluation of traditional manufacturing models, increasing the demand for flexible and modular production infrastructure.
Sustainability initiatives—including single-use technologies, waste minimization, and resource-efficient practices—are becoming industry standards, reducing operational risk and aligning with evolving stakeholder expectations.
Competitive pressures are encouraging manufacturers to invest in digital upskilling, workforce adaptability, and collaborative supply chain ecosystems to ensure regulatory compliance and market responsiveness.
Regional clusters such as North America, Europe, India, and China are strengthening leadership through API infrastructure investment, regulatory harmonization, and increased cross-border collaboration.

Tariff Impact: U.S. Regulatory and Cost Pressures

Recent U.S. tariffs on select pharmaceutical inputs and finished products have driven manufacturers to reassess sourcing, increase domestic API production, and form new contract manufacturing partnerships. These shifts are prompting a move toward localized supply ecosystems and the adoption of agile procurement strategies to safeguard margins and ensure reliable access to key components.

Methodology & Data Sources

This analysis combines primary interviews with industry executives, manufacturing leaders, and regulatory experts, alongside secondary research from peer-reviewed journals, industry reports, and regulatory filings. Advanced data triangulation and segmentation analytics ensure findings are accurate, credible, and actionable for senior stakeholders.

Why This Report Matters

Enables strategic investment decisions by mapping out emerging production innovations and risk factors in the pharmaceutical manufacturing market.
Arms leaders with actionable intelligence to address compliance, supply chain volatility, and technological integration across multiple segments and geographies.
Supports long-term capacity, resilience, and growth planning amid increasing global competition and shifting policy landscapes.

Conclusion

The pharmaceutical manufacturing landscape is transforming through new technologies, evolving regulations, and rising stakeholder expectations. This report equips decision-makers with the insights required to align operations, innovation, and sustainability for future industry leadership.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Market Sizing & Forecasting

5. Market Dynamics

5.1. Adoption of continuous flow reactors with real-time quality monitoring in active pharmaceutical ingredient synthesis
5.2. Deployment of advanced single-use bioreactor systems for flexible cell culture manufacturing
5.3. Integration of AI-driven predictive analytics in process optimization for biologics production
5.4. Implementation of digital twin technology for end-to-end pharmaceutical manufacturing transparency
5.5. Scaling up mRNA vaccine production through modular facility design and automation
5.6. Application of novel green solvent technologies to enhance sustainable drug compound extraction
5.7. Enhancing supply chain resilience through blockchain-enabled cold chain tracking solutions

6. Market Insights

6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Pharmaceutical Manufacturing Market, by Drug Type

8.1. Introduction
8.2. Biosimilars
8.3. Branded Drugs
8.4. Generic Drugs

9. Pharmaceutical Manufacturing Market, by Dosage Form

9.1. Introduction
9.2. Liquid Dosage Forms
9.2.1. Emulsion
9.2.2. Solution
9.2.3. Suspension
9.3. Parenteral Dosage Forms
9.3.1. Infusion Forms
9.3.2. Injectable Forms
9.3.2.1. Prefilled Syringe
9.3.2.2. Vial
9.4. Solid Dosage Forms
9.4.1. Capsule
9.4.2. Powder
9.4.3. Tablet

10. Pharmaceutical Manufacturing Market, by Manufacturing Stage

10.1. Introduction
10.2. API Manufacturing
10.3. Formulation Manufacturing
10.4. Packaging And Labelling

11. Pharmaceutical Manufacturing Market, by Molecule Type

11.1. Introduction
11.2. Large Molecule Drugs
11.3. Small Molecule Drugs

12. Pharmaceutical Manufacturing Market, by Manufacturing Technology

12.1. Introduction
12.2. Batch Manufacturing
12.3. Continuous Manufacturing
12.4. Single-Use Technology

13. Pharmaceutical Manufacturing Market, by End-User

13.1. Introduction
13.2. Biotechnology Companies
13.3. Contract Research Organizations (CROs)
13.4. Government/Public Health Bodies
13.5. Pharmaceutical Companies
13.6. Research Organizations & Academic Institutes

14. Pharmaceutical Manufacturing Market, by Therapeutic Area

14.1. Introduction
14.2. Cardiovascular
14.3. Endocrinology (e.g., Diabetes)
14.4. Gastroenterology
14.5. Immunology
14.6. Infectious Diseases
14.7. Neurology
14.8. Oncology
14.9. Rare Diseases
14.10. Respiratory

15. Americas Pharmaceutical Manufacturing Market

15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina

16. Europe, Middle East & Africa Pharmaceutical Manufacturing Market

16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland

17. Asia-Pacific Pharmaceutical Manufacturing Market

17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan

18. Competitive Landscape

18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Pfizer Inc.
18.3.2. Roche Holding AG
18.3.3. Johnson & Johnson
18.3.4. Merck KGaA
18.3.5. Novartis AG
18.3.6. AbbVie Inc.
18.3.7. Sanofi S.A.
18.3.8. AstraZeneca plc
18.3.9. Eli Lilly and Company
18.3.10. ACG Pvt. Ltd.
18.3.11. Mankind Pharma Ltd.

19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix

List of Figures

FIGURE 1. PHARMACEUTICAL MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. PHARMACEUTICAL MANUFACTURING MARKET: RESEARCHAI
FIGURE 30. PHARMACEUTICAL MANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 31. PHARMACEUTICAL MANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 32. PHARMACEUTICAL MANUFACTURING MARKET: RESEARCHARTICLES

List of Tables

TABLE 1. PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY EMULSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY EMULSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING AND LABELLING, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING AND LABELLING, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LARGE MOLECULE DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LARGE MOLECULE DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SMALL MOLECULE DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS (CROS), BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GOVERNMENT/PUBLIC HEALTH BODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GOVERNMENT/PUBLIC HEALTH BODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESEARCH ORGANIZATIONS & ACADEMIC INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ENDOCRINOLOGY (E.G., DIABETES), BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ENDOCRINOLOGY (E.G., DIABETES), BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY RESPIRATORY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 129. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 130. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 160. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 161. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 162. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 163. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 164. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 165. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 166. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 167. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 168. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 169. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 170. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 171. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 172. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 173. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 176. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 177. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 180. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 181. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 198. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MOLECULE TYPE, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 289. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2024 (USD MILLION)
TABLE 290. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2025-2030 (USD MILLION)
TABLE 291. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 292. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 293. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2024 (USD MILLION)
TABLE 296. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2025-2030 (USD MILLION)
TABLE 297. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2024 (USD MI

Samples

LOADING...

Companies Mentioned

Pfizer Inc.
Roche Holding AG
Johnson & Johnson
Merck KGaA
Novartis AG
AbbVie Inc.
Sanofi S.A.
AstraZeneca plc
Eli Lilly and Company
ACG Pvt. Ltd.
Mankind Pharma Ltd.

Table Information

Report Attribute	Details
No. of Pages	187
Published	August 2025
Forecast Period	2025 - 2030
Estimated Market Value ( USD ) in 2025	$ 731.63 Billion
Forecasted Market Value ( USD ) by 2030	$ 1110 Billion
Compound Annual Growth Rate	8.7%
Regions Covered	Global
No. of Companies Mentioned	11

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Site License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

Request Invoice or Quote

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3147EUR$3,545USD£2,730GBP €3497EUR$3,939USD£3,034GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3395EUR$3,824USD£2,945GBP €3772EUR$4,249USD£3,272GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4602EUR$5,183USD£3,992GBP €5113EUR$5,759USD£4,435GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€5568EUR$6,272USD£4,830GBP €6187EUR$6,969USD£5,367GBP

Market Snapshot: Pharmaceutical Manufacturing Market Size & Growth

Scope & Segmentation: Market Structure and Coverage

Key Takeaways for Senior Decision-Makers

Tariff Impact: U.S. Regulatory and Cost Pressures

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Samples

Companies Mentioned

Table Information

Related Topics

Related Reports

Pharmaceutical Manufacturing Global Market Report 2025

Pharmaceutical Contract Development & Manufacturing Market by Service Type (Contract Development Services, Contract Manufacturing Services), Development Stage (Clinical, Commercial, Preclinical), End Use, Customer Type - Global Forecast 2025-2030

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast 2025-2030

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

Oral Solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Tablets, Capsules, Powders, Granules), Mechanism (Controlled Release, Immediate Release), End-use, and Region with Growth Forecasts, 2025-2030

About the Pharmaceutical Manufacturing Market